Clinical Trials Browser

Recruiting × Duloxetine Hydrochloride × Other hematologic neoplasm × Clear all

NCT04560673 2025-12-31

Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms